AU5001793A - Method of decreasing cutaneous senescence - Google Patents

Method of decreasing cutaneous senescence

Info

Publication number
AU5001793A
AU5001793A AU50017/93A AU5001793A AU5001793A AU 5001793 A AU5001793 A AU 5001793A AU 50017/93 A AU50017/93 A AU 50017/93A AU 5001793 A AU5001793 A AU 5001793A AU 5001793 A AU5001793 A AU 5001793A
Authority
AU
Australia
Prior art keywords
decreasing
senescence
cutaneous senescence
decreasing cutaneous
cutaneous
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU50017/93A
Inventor
Gregory L Brown
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bays-Brown Dermatologics Inc
Original Assignee
Bays-Brown Dermatologics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bays-Brown Dermatologics Inc filed Critical Bays-Brown Dermatologics Inc
Publication of AU5001793A publication Critical patent/AU5001793A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1808—Epidermal growth factor [EGF] urogastrone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1825—Fibroblast growth factor [FGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1858—Platelet-derived growth factor [PDGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/30—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU50017/93A 1992-08-12 1993-08-10 Method of decreasing cutaneous senescence Abandoned AU5001793A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US92826492A 1992-08-12 1992-08-12
US928264 1992-08-12
PCT/US1993/007470 WO1994004184A2 (en) 1992-08-12 1993-08-10 Method of decreasing cutaneous senescence

Publications (1)

Publication Number Publication Date
AU5001793A true AU5001793A (en) 1994-03-15

Family

ID=25455979

Family Applications (1)

Application Number Title Priority Date Filing Date
AU50017/93A Abandoned AU5001793A (en) 1992-08-12 1993-08-10 Method of decreasing cutaneous senescence

Country Status (2)

Country Link
AU (1) AU5001793A (en)
WO (1) WO1994004184A2 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR1002807B (en) 1996-06-20 1997-11-13 Lavipharm A.E. Device for topical treatment of acne and method of manufacture.
US6306432B1 (en) * 1997-09-08 2001-10-23 Chiron Corporation High and low load formulations of IGF-I in multivesicular liposomes
FR2828400B1 (en) * 2001-08-10 2003-11-07 Oreal COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING AN ASSOCIATION BETWEEN IGF1 AND / OR AN IGF1 MIMETIC COMPOUND, AND AT LEAST ONE RETINOIDE AND / OR AT LEAST ONE RETINOID DERIVATIVE
FR2828401B1 (en) * 2001-08-10 2003-11-07 Oreal COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING AN ASSOCIATION BETWEEN IGF1 AND / OR A MIMETIC COMPOUND OF IGF1, AND ASCORBIC ACID AND / OR AT LEAST ONE OF ITS DERIVATIVES
US6821524B2 (en) * 2002-06-03 2004-11-23 Jan Marini Skin Research, Inc. Cosmetic skin care compositions
FR2854328B1 (en) * 2003-04-29 2006-08-04 Rocher Yves Biolog Vegetale COSMETIC OR DERMATOLOGICAL OR PHARMACEUTICAL COMPOSITION CONTAINING A PEPTIDE-LIKE GROWTH FACTOR OF PLANT TYPE
WO2008116116A2 (en) 2007-03-20 2008-09-25 Harold Brem Gm-csf cosmeceutical compositions and methods of use thereof
US20080234194A1 (en) 2007-03-20 2008-09-25 Harold Brem Growth factor mediated cosmeceuticals and use thereof to enhance skin quality
US9808654B2 (en) 2013-02-11 2017-11-07 Jan Marini Skin Research Post procedure skin care gel and methods of use thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS615006A (en) * 1984-06-19 1986-01-10 Sanki Shoji Kk Agent for skin
JPS6115810A (en) * 1984-06-30 1986-01-23 Nonogawa Shoji:Kk Cosmetic
JPH0657652B2 (en) * 1985-07-19 1994-08-03 鐘紡株式会社 Skin aging prevention cosmetics
LU87624A1 (en) * 1989-11-16 1991-07-22 Oreal PHARMACEUTICAL AND / OR COSMETIC COMPOSITION CONTAINING A HYPOPHYSISAL GROWTH FACTOR (HDGF) STABILIZED BY SOLUBLE ELASTINE
IT1239271B (en) * 1990-02-27 1993-10-01 Fidia Spa PROCESS FOR THE EXPRESSION OF THE HUMAN NERVE GROWTH FACTOR IN ARROPODA FRUGIPERDA CELLS VIA INFECTION WITH RECOMBINANT BACULOVIRUS
JP2955718B2 (en) * 1990-05-24 1999-10-04 株式会社資生堂 External preparation for skin
US5219998A (en) * 1990-06-04 1993-06-15 Levin Robert H Yeast-derived epidermal growth factor
JP2982078B2 (en) * 1990-10-05 1999-11-22 アース製薬株式会社 Canine epidermal growth factor, anti-inflammatory agent or cosmetic containing the canine epidermal growth factor as an active ingredient, and method for producing canine epidermal growth factor cEGF
JPH0543442A (en) * 1991-08-14 1993-02-23 Sansho Seiyaku Co Ltd Skin cosmetic

Also Published As

Publication number Publication date
WO1994004184A2 (en) 1994-03-03
WO1994004184A3 (en) 1994-06-23

Similar Documents

Publication Publication Date Title
AU4013193A (en) Method of maintaining relationships between elements
AU5621594A (en) 5-methanesulfonamido-1-indanones as an inhibitor of cyclooxygenase-2
AU1002192A (en) Combined method of determining fires
AU4873193A (en) Use of substituted benzimidazoles
AU1322195A (en) Method of assay
AU5218593A (en) Method of milling
AU1448092A (en) Splitter and method of forming it
AU4772493A (en) Sulfo-derivatives of adenosine
AU4233593A (en) Moving harness and method of use
AU1169092A (en) Method of brazing
AU4868493A (en) Method of combining polymers
AU5323694A (en) 17beta -carboxanilides of 4-aza-5alpha-androstan-3-ones as 5alpha-reductase inhibitors
AU8155294A (en) Methods of inhibiting sexual precocity
AU6752294A (en) Preparation process of acrylamide
AU5001793A (en) Method of decreasing cutaneous senescence
AU3385693A (en) Determination method
AU8016094A (en) Method of contraception
AU5184393A (en) Substituted derivatives of diaminophthalimide
AU6109096A (en) Methods of inhibiting melanoma
AU6723294A (en) Use of simmondsine
AU3359493A (en) Determination of haptens
AU3477093A (en) 17beta -hydroxybenzoyl-4-aza-5alpha-androst-1-en-3-ones useful to treat baldness
AU5149793A (en) Method of preparing aminoalkylhydantoins and aminoalkyl-alpha-aminoacids
RU2003311C1 (en) Method of blepharorrhaphy
AU5429894A (en) Block of paint and its use